glutathione rapta c Structures of RAPTA-C and of a generic RANHC Integrative Therapeutics Glutathione Cell Defense
Integrative Therapeutics Glutathione Cell Defense Anticancer activity of RAPTA EA1 in triple negative BRCA1 proficient breast cancer cells: single and combined treatment with the PARP inhibitor olaparib ScienceDirect Anti cancer organoruthenium( ii ) complexes and their interactions with cysteine and its analogues. A mass spectrometric study Dalton Transactions (RSC Publishing) DOI:10.1039 C8DT04350G Combinative Treatment of the PARP Inhibitor Olaparib and Antimetastasis Ruthenium(II)Arene Compound RAPTA T for Triple Negative BRCA1 Wild Type Breast Cancer Cells
Pay in 4 interest-free payments of $6.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3



